Neurology India
Open access journal indexed with Index Medicus
  Users online: 860  
 Home | Login 
  About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe Etcetera Contact  
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1259    
    Printed38    
    Emailed0    
    PDF Downloaded101    
    Comments [Add]    

Recommend this journal

 

 NI FEATURE: PATHOLOGY PANORAMA - COMMENTARY
Year : 2017  |  Volume : 65  |  Issue : 2  |  Page : 315--332

Indian Society of Neuro-Oncology consensus guidelines for the contemporary management of medulloblastoma


1 Neuro-Oncology Disease Management Group, Tata Memorial Centre, Mumbai, Maharashtra, India
2 Division of Neuro-pathology, All India Institute of Medical Sciences, New Delhi, India
3 Department of Neuro-surgery, Christian Medical College and Hospital, Vellore, Tamil Nadu, India
4 Department of Neuro-surgery, Park Clinic, Kolkata, West Bengal, India
5 Department of Neuro-surgery, King Edward Memorial Hospital, Mumbai, Maharashtra, India
6 Division of Radio-diagnosis and Imaging, Global Hospital, Mumbai, Maharashtra, India

Correspondence Address:
Tejpal Gupta
Radiation Oncology, Convener, Neuro-Oncology Disease Management Group, ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai - 410. 210, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.201841

Rights and Permissions

Introduction: The high success rate in the management medulloblastoma achieved in the western world is not exactly mirrored in developing countries including India. Socio-demographic differences, health-care disparity, and lack in uniformity of care with resultant widespread variations in the clinical practice are some of the reasons that may partly explain this difference in outcomes. Patients with medulloblastoma require a multi-disciplinary team approach involving but not limited to neuro-radiology, neurosurgery; neuropathology, molecular biology, radiation oncology, pediatric medical oncology and rehabilitative services for optimizing outcomes. Methods: The Indian Society of Neuro-Oncology (ISNO) constituted an expert multi-disciplinary panel with adequate representation from all stakeholders to prepare national consensus guidelines for the contemporary management of medulloblastoma. Results: Minimum desirable, as well as preferable though optional recommendations (as appropriate), were developed and adopted for the pre-surgical work-up including neuroimaging; neurosurgical management including surgical principles, techniques, and complications; neuropathology reporting and molecular testing; contemporary risk-stratification in the molecular era; appropriate adjuvant therapy (radiotherapy and chemotherapy); and follow-up schedule in medulloblastoma. Conclusions: The current document represents a broad consensus reached amongst various stakeholders within the neuro-oncology community involved in the contemporary curative-intent management of children with medulloblastoma. It provides both general as well as specific guidelines and recommendations to be adopted by physicians and health care providers across India to achieve uniformity of care, improve disease-related outcomes, and compare results between institutions within the country.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow